Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in China

Peking Union Medical College Hospital (East) - Dongdan Campus /ID# 233179, Beijing

Peking University International Hospital /ID# 232254, Beijing

The First Affiliated Hospital of Soochow University /ID# 232418, Suzhou

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc /ID# 232253, Tianjin

The First Affiliated Hospital of Wenzhou Medical University /ID# 233704, Wenzhou

The First Affiliated Hospital of Nanchang University /ID# 231442, Nanchang

Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 233178, Wuhan

Xiangyang Central Hospital /ID# 232452, Xiangyang

People's Hospital of Henan Province /ID# 232568, Zhengzhou

Henan Cancer Hospital /ID# 231940, Zhengzhou

Sun Yat-Sen University Cancer Center /ID# 231793, Guangzhou

Zhujiang Hospital of Southern Medical University /ID# 231792, Guangzhou

Guangdong Second Provincial General Hospital /ID# 232059, Guangzhou

Nanfang Hospital of Southern Medical University /ID# 231938, Guangzhou

Shenzhen Second People's Hospital /ID# 231444, Shenzhen

Duplicate_The Affiliated Hospital of Guizhou Medical University /ID# 232465, Guiyang

The Second People's Hospital of Yibin /ID# 233180, Yibin

Qinghai University Affiliated Hospital /ID# 232419, Xining